Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jul;85(1):23–28. doi: 10.1054/bjoc.2001.1859

Body surface area estimation in children using weight alone: application in paediatric oncology

I Sharkey 1, A V Boddy 2, H Wallace 3, J Mycroft 4, R Hollis 5, S Picton 5, on behalf of the Chemotherapy Standardisation group of the United Kingdom Children's Cancer Study Group
PMCID: PMC2363913  PMID: 11437397

Abstract

The majority of chemotherapy regimens and trials specify doses of cytotoxic drugs normalized to body surface area. Estimation of BSA in paediatric patients is particularly problematic, as conventional nomograms require accurate determination of both height and weight. The chemotherapy standards group of the UKCCSG (United Kingdom Children's Cancer Study Group) has evaluated a method for calculation of body surface area (BSA) estimation, based solely on patient weight. In comparison with BSA estimations using 2 commonly used methods, which require both weight and height measurements, deviation in the estimate of BSA was less than 10%. This method may be extended to the dosing of chemotherapeutic agents in infants of body weight less than 10 kg, with appropriate recommendations for dose modification. Until better correlates of drug clearance, such as GFR for carboplatin, are identified BSA is used to standardize doses for most chemotherapeutic agents. The formula presented here provides a more robust and reliable method of calculation of BSA from weight alone. Although this approach has been shown to be equivalent to other currently used methods, care should be taken extending this calculation of BSA to children less than 10 kg, to obese patients and to those with cachexia. © 2001 Cancer Research Campaign http://www.bjcancer.com

Full Text

The Full Text of this article is available as a PDF (62.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blanco J. G., Harrison P. L., Evans W. E., Relling M. V. Human cytochrome P450 maximal activities in pediatric versus adult liver. Drug Metab Dispos. 2000 Apr;28(4):379–382. [PubMed] [Google Scholar]
  2. Boos J., Krümpelmann S., Schulze-Westhoff P., Euting T., Berthold F., Jürgens H. Steady-state levels and bone marrow toxicity of etoposide in children and infants: does etoposide require age-dependent dose calculation? J Clin Oncol. 1995 Dec;13(12):2954–2960. doi: 10.1200/JCO.1995.13.12.2954. [DOI] [PubMed] [Google Scholar]
  3. Calvert A. H., Newell D. R., Gumbrell L. A., O'Reilly S., Burnell M., Boxall F. E., Siddik Z. H., Judson I. R., Gore M. E., Wiltshaw E. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol. 1989 Nov;7(11):1748–1756. doi: 10.1200/JCO.1989.7.11.1748. [DOI] [PubMed] [Google Scholar]
  4. Coulthard M. G. Surface area is best estimated from weight alone: pocket calculators and nomograms are unnecessary. Arch Dis Child. 1994 Sep;71(3):281–281. doi: 10.1136/adc.71.3.281-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crom W. R., Glynn-Barnhart A. M., Rodman J. H., Teresi M. E., Kavanagh R. E., Christensen M. L., Relling M. V., Evans W. E. Pharmacokinetics of anticancer drugs in children. Clin Pharmacokinet. 1987 Mar;12(3):168–213. doi: 10.2165/00003088-198712030-00002. [DOI] [PubMed] [Google Scholar]
  6. Crom W. R., Relling M. V., Christensen M. L., Rivera G. K., Evans W. E. Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrine. Clin Pharmacol Ther. 1991 Aug;50(2):132–140. doi: 10.1038/clpt.1991.117. [DOI] [PubMed] [Google Scholar]
  7. Desoize B., Robert J. Individual dose adaptation of anticancer drugs. Eur J Cancer. 1994;30A(6):844–851. doi: 10.1016/0959-8049(94)90304-2. [DOI] [PubMed] [Google Scholar]
  8. Evans W. E., Relling M. V., Rodman J. H., Crom W. R., Boyett J. M., Pui C. H. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. N Engl J Med. 1998 Feb 19;338(8):499–505. doi: 10.1056/NEJM199802193380803. [DOI] [PubMed] [Google Scholar]
  9. FRIIS-HANSEN B. Body water compartments in children: changes during growth and related changes in body composition. Pediatrics. 1961 Aug;28:169–181. [PubMed] [Google Scholar]
  10. Galpin A. J., Evans W. E. Therapeutic drug monitoring in cancer management. Clin Chem. 1993 Nov;39(11 Pt 2):2419–2430. [PubMed] [Google Scholar]
  11. George S. L., Gehan E. A. Methods for measurement of body surface area. J Pediatr. 1979 Feb;94(2):342–343. doi: 10.1016/s0022-3476(79)80870-7. [DOI] [PubMed] [Google Scholar]
  12. Gurney H. Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative. J Clin Oncol. 1996 Sep;14(9):2590–2611. doi: 10.1200/JCO.1996.14.9.2590. [DOI] [PubMed] [Google Scholar]
  13. Haycock G. B., Schwartz G. J., Wisotsky D. H. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr. 1978 Jul;93(1):62–66. doi: 10.1016/s0022-3476(78)80601-5. [DOI] [PubMed] [Google Scholar]
  14. Newell D. R., Pearson A. D., Balmanno K., Price L., Wyllie R. A., Keir M., Calvert A. H., Lewis I. J., Pinkerton C. R., Stevens M. C. Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group. J Clin Oncol. 1993 Dec;11(12):2314–2323. doi: 10.1200/JCO.1993.11.12.2314. [DOI] [PubMed] [Google Scholar]
  15. PINKEL D. The use of body surface area as a criterion of drug dosage in cancer chemotherapy. Cancer Res. 1958 Aug;18(7):853–856. [PubMed] [Google Scholar]
  16. Ratain M. J. Body-surface area as a basis for dosing of anticancer agents: science, myth, or habit? J Clin Oncol. 1998 Jul;16(7):2297–2298. doi: 10.1200/JCO.1998.16.7.2297. [DOI] [PubMed] [Google Scholar]
  17. SENDROY J., Jr, CECCHINI L. P. Determination of human body surface area from height and weight. J Appl Physiol. 1954 Jul;7(1):1–12. doi: 10.1152/jappl.1954.7.1.1. [DOI] [PubMed] [Google Scholar]
  18. Woods W. G., O'Leary M., Nesbit M. E. Life-threatening neuropathy and hepatotoxicity in infants during induction therapy for acute lymphoblastic leukemia. J Pediatr. 1981 Apr;98(4):642–645. doi: 10.1016/s0022-3476(81)80785-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES